Author:
Hand Ivan L.,Noble Lawrence,Geiss Donna,Shotkin Alan
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Infectious Diseases,Microbiology (medical),Pediatrics, Perinatology, and Child Health
Reference8 articles.
1. Respiratory syncytial virus-coded pediatric hospitalizations, 1997 to 1999.;Leader;Pediatr Infect Dis J,2002
2. Immunoprophylaxis with palivizumab, a humanized monoclonal antibody, for prevention of respiratory syncytial virus infection in high risk infants: a consensus opinion.;Meissner;Pediatr Infect Dis J,1999
3. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduced hospitalization from respiratory syncytial virus infection in high-risk infants.;Pediatrics,1998
4. Palivizumab prophylaxis for respiratory syncytial virus in Canada: utilization and outcomes.;Oh;Pediatr Infect Dis J,2002
5. Factors predicting compliance with palivizumab in high-risk infants.;Langkamp;Am J Perinatol,2001
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献